Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Morgan Stanley

Start price
€212.40
03.08.23 / 50%
Target price
€290.24
03.08.24
Performance (%)
32.72%
End price
€281.90
04.08.24
Summary
This prediction ended on 04.08.24 with a price of €281.90. The BUY prediction by Morgan_Stanley for United Therapeutics saw massive gains of 32.72%. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
United Therapeutics 2.646% 2.646% 69.722% 111.269%
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by Morgan_Stanley for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) 32.72%
Target price 290.239
Change
Ends at 03.08.24

United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Morgan Stanley from $316.00 to $318.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat

In the thread Trading United Therapeutics
Prediction Buy
Perf. (%) 32.72%
Target price 290.239
Change
Ends at 03.08.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten